Suggamadex and Fast-track Cardiac Anesthesia in a Developing Country

Joseph D. Tobias14 enrolled

Overview

The purpose of this study is to retrospectively review our preliminary experience during a surgical trip to Tuxtla, Mexico, using suggamadex to reverse neuromuscular blockade following CPB and cardiac surgery for repair of CHD in infants and children.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Suggamadex Surgery for Congenital Heart Disease

Interventions

SurgeryPROCEDURE

Sugammadex to reverse neuromuscular blockade

Eligibility

Sex: ALLMin age: 0 YearsMax age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients who underwent cardiac surgery and cardiopulmonary bypass in Tuxtla, Mexico in September 2015. Exclusion Criteria: * None

Locations (1)

Nationwide Children's Hospital

Columbus, Ohio, United States

Outcomes

Primary Outcomes

Clinical effects of the reversal of neuromuscular blockade with suggamadex following surgery for congenital heart disease in infants and children

Time frame: After cardiac surgery, on average within 5 minutes

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.